Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Candidiasis, Oral

glucose, (beta-d)-isomer has been researched along with Candidiasis, Oral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kreft, B; Moldenhauer, I; Pliquett, RU; Sunderkötter, C	1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Candidiasis, Oral

Article	Year
Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor - SGLT2-inhibitor). Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2019, Volume: 17, Issue:4 Topics: Administration, Oral; Angioedema; Antibodies, Monoclonal, Humanized; Antifungal Agents; Benzhydryl Compounds; Candida albicans; Candidiasis, Oral; Candidiasis, Vulvovaginal; Female; Fluconazole; Foreskin; Glucosides; Humans; Male; Middle Aged; Missed Diagnosis; Penis; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome	2019

Article

Year

Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor - SGLT2-inhibitor).

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2019, Volume: 17, Issue:4

Topics: Administration, Oral; Angioedema; Antibodies, Monoclonal, Humanized; Antifungal Agents; Benzhydryl Compounds; Candida albicans; Candidiasis, Oral; Candidiasis, Vulvovaginal; Female; Fluconazole; Foreskin; Glucosides; Humans; Male; Middle Aged; Missed Diagnosis; Penis; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome

2019